Higher plant protein intake linked to lower risk of chronic kidney disease

Plant-based diets confer various health benefits, including lowering the risk of cardiovascular disease and certain cancers.

Cidara’s $100M PIPE; Pyxis Oncology’s stock falls on Phase 1 data

Plus, news about argenx, Forte Biosciences, Verrica, Pep2Tango Therapeutics, Eli Lilly, Laekna, Lineage Cell Therapeutics and OneCell Diagnostics: Cidara Therapeutics nabs $105M: The immunotherapy maker

November 22, 2024

Boston Scientific gives first look at Farapulse US rollout

By the numbers Q1 sales: $3.86 billion 13.8% increase year over year Cardiovascular sales: $2.45 billion Nearly 16% increase year over year Net income: $493

April 24, 2024

Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected – Biotech Investments

Evolva Holding SA / Key word(s): AGMEGM 12-Apr-2024 / 16:56 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is

April 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.